LQDA
Liquidia Corporation · Healthcare · Medical - Pharmaceuticals
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.3% ·
aandelenstroom -1.8% ·
netto nieuwe posities -15.4%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +24 | 36.67M | $2.92B | +27 | −3 |
| Q1 2026 | 79 | -1 | 26.51M | $999.68M | +6 | −8 |
| Q4 2025 | 81 | 0 | 26.44M | $911.45M | +1 | — |
| Q3 2025 | 17 | +1 | 21.94M | $498.92M | +1 | — |
| Q2 2025 | 13 | -2 | 14.83M | $184.82M | — | −2 |
| Q1 2025 | 12 | 0 | 5.71M | $84.24M | — | — |
| Q4 2024 | 12 | +4 | 4.81M | $56.51M | +4 | — |
| Q3 2024 | 7 | -2 | 2.07M | $20.68M | +1 | −3 |
| Q2 2024 | 9 | — | 2.26M | $27.08M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 4.89M | — | $60.96M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 3.59M | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 3.59M | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 3.59M | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 3.59M | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 3.59M | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passief) | 1.83M | +2.4% | $22.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 1.41M | +2.4% | $17.52M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 1.41M | +2.4% | $17.52M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 914.49K | — | $11.39M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 914.49K | — | $11.39M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 747.00K | +72.1% | $9.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 660.76K | +58.6% | $8.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 660.76K | +58.6% | $8.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Marshall Wace ✦ | 660.76K | +58.6% | $8.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 370.95K | -26.8% | $4.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 203.98K | +4.0% | $2.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 203.98K | +4.0% | $2.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 203.98K | +4.0% | $2.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 203.98K | +4.0% | $2.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 203.98K | +4.0% | $2.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 146.44K | -10.9% | $1.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 146.44K | -10.9% | $1.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 32.06K | +17.1% | $400,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Millennium Management ✦ | 20.58K | -83.5% | $256,414 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 14.72K | -11.1% | $183,423 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 14.72K | -11.1% | $183,423 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 14.72K | -11.1% | $183,423 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Adage Capital Partners | $6.80M | was 0.0% |
| Renaissance Technologies | $2.98M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 242 houders, 61.34M aandelen, $2.26B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 41.83K aand · $2.89M
Officer · 31.80K aand · $2.20M
Director · 18.39K aand · $1.33M
Director · 36.79K aand · $2.76M
Officer · 50.00K aand · $3.70M
Officer · 29.53K aand · $2.27M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie